Insulin in the Treatment of Dry Eye Disease: The New Alternative
EyeQuest · 2025
DOI: 10.4103/equest.equest_11_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift EyeQuest, 2025. Verfasst von Sonali Prasad und 1 weiteren Autor:innen. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Dry eye disease is a complex disorder marked by tear film instability, chronic inflammation, and neurosensory issues. It's more common in people with diabetes, autoimmune conditions like Sjögren's, and older adults. Current treatments—such as artificial tears, anti-inflammatories, and serum eye drops—often provide only limited relief, underscoring the need for additional options. Interest in insulin as a treatment emerged from observations of poor wound healing and worsened DED in diabetics lacking insulin signaling. Insulin receptors on corneal and conjunctival cells suggest insulin may directly benefit ocular surface health.
Zitieren
APA
Prasad, S., & Prasad, S. (2025). Insulin in the Treatment of Dry Eye Disease: The New Alternative. EyeQuest. https://doi.org/10.4103/equest.equest_11_25
Vancouver
Prasad S, Prasad S. Insulin in the Treatment of Dry Eye Disease: The New Alternative. EyeQuest. 2025. doi:10.4103/equest.equest_11_25
BibTeX
@article{Prasad2025,
author = {Prasad, Sonali and Prasad, Subhash},
title = {Insulin in the Treatment of Dry Eye Disease: The New Alternative},
journal = {EyeQuest},
year = {2025},
doi = {10.4103/equest.equest_11_25}
}
EUVIMED